» Articles » PMID: 6469353

Antibody in Host Defense Against Mouse Pneumonitis Agent (murine Chlamydia Trachomatis)

Overview
Journal Infect Immun
Date 1984 Sep 1
PMID 6469353
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In a murine model of chlamydial pneumonia employing murine Chlamydia trachomatis, immune serum given intranasally delayed death in nude (nu/nu) mice and prevented death in nu/+ mice. Serum-derived immunoglobulin G and A fractions and immune lavage fluid fractions containing immunoglobulins G and A were effective in producing protection when used to opsonize the murine C. trachomatis inoculum. In hyperclean mice (previously made germfree and then colonized with a limited flora nonpathogenic to mice) antibody given intravenously was ineffective. The effects of antibody and nonspecific stimulation of cell-mediated immunity (after previous infection with Histoplasma capsulatum) were additive in increasing host resistance to murine C. trachomatis.

Citing Articles

Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Yang Z, Conrad T, Zhou Z, Chen J, Dutow P, Klos A Infect Immun. 2014; 82(8):3154-63.

PMID: 24842924 PMC: 4136226. DOI: 10.1128/IAI.01833-14.


Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens.

Armitage C, OMeara C, Harvie M, Timms P, Blumberg R, Beagley K Immunol Cell Biol. 2014; 92(5):417-26.

PMID: 24445600 PMC: 4088937. DOI: 10.1038/icb.2013.110.


Perforin is detrimental to controlling [corrected] C. muridarum replication in vitro, but not in vivo.

Johnson R, Kerr M, Slaven J PLoS One. 2013; 8(5):e63340.

PMID: 23691028 PMC: 3653963. DOI: 10.1371/journal.pone.0063340.


A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.

Bode J, Dutow P, Sommer K, Janik K, Glage S, Tummler B PLoS One. 2012; 7(11):e50327.

PMID: 23189195 PMC: 3506576. DOI: 10.1371/journal.pone.0050327.


T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Yang X, Brunham R Can J Infect Dis. 2012; 9(2):99-108.

PMID: 22451777 PMC: 3307538. DOI: 10.1155/1998/395297.


References
1.
Tagliabue A, Nencioni L, Villa L, Keren D, Lowell G, Boraschi D . Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature. 1983; 306(5939):184-6. DOI: 10.1038/306184a0. View

2.
Brunham R, Kuo C, Cles L, Holmes K . Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun. 1983; 39(3):1491-4. PMC: 348123. DOI: 10.1128/iai.39.3.1491-1494.1983. View

3.
Wang S, GRAYSTON J . Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol. 1970; 70(3):367-74. DOI: 10.1016/0002-9394(70)90096-6. View

4.
Nichols R, Oertley R, Fraser E, MacDONALD A, McComb D . Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma. J Infect Dis. 1973; 127(4):429-32. DOI: 10.1093/infdis/127.4.429. View

5.
MURRAY E, Charbonnet L, MacDONALD A . Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis. J Immunol. 1973; 110(6):1518-25. View